Table 2.

Clinical parameters between the two groups of lymphoma patients (NHL and HL). Student’s t-test was applied unpaired between NHL vs. HL, p < 0.05 statistically significant.

	NHL	HL	SIGNIFICANCE
NUM	63	10
STAGE I	0.09 ± 0.29	0.1 ± 0.31	p-value = 0.96
STAGE II	0.15 ± 0.36	0.4 ± 0.51	p-value = 0.07
STAGE III	0.25 ± 0.43	0.1 ± 0.31	p-value = 0.29
STAGE IV	0.49 ± 0.50	0.4 ± 0.51	p-value = 0.59
CNS involvement	0.26 ± 0.44	0.2 ± 0.42	p-value = 0.64
HBV	0.20 ± 0.40	0.1 ± 0.31	p-value = 0.43
HCV	0.063 ± 0.24	0	p-value = 0.41
SYMPTOMS B	0.34 ± 0.48	0.5 ± 0.52	p-value = 0.36